News & Updates

Join us at the 1st Advanced Therapies Science Meeting in Berlin

Posted on October 2, 2019 by Stefanie Seltmann The 1st Advanced Therapies Science Meeting from Restore will take place at 25. and 26. November 2019 in Berlin. Dr. Andreas Kurtz from hPSCreg will talk about "Ethics management" and "Stem cell data standards". We hope to meet you at the meeting and look forward to fruitful discussions. ... Continue reading

Current status: 746 hESC lines, 2079 hiPSC lines, and 42 clinical studies

Posted on October 1, 2019 by Statistic Bot ... Continue reading
Total lines2825
hESC lines746
hiPSC lines2079
derivation countries32
projects 141
providers374
... Continue reading

new publication on ethical provenance of cell lines

Posted on August 23, 2019 by Stefanie Seltmann We are happy that our new publication "A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSCreg)" has been released. You can find the publication here
Total lines2783
hESC lines746
hiPSC lines2037
derivation countries32
projects 140
providers366
... Continue reading

Current status: 744 hESC lines, 1974 hiPSC lines, and 39 clinical studies

Posted on August 1, 2019 by Statistic Bot ... Continue reading

Please take part in the User Survey from EBiSC

Posted on July 23, 2019 by Stefanie Seltmann The European Bank of induced pluripotent Stem Cells EBiSC is looking for your input as international iPSC scientists. The user survey to gather feedback on your requirements from an iPSC repository is now available . This includes assessing provision of: Specific disease variant iPSCs
Total lines2718
hESC lines744
hiPSC lines1974
derivation countries32
projects 139
providers359
... Continue reading

Current status: 744 hESC lines, 1949 hiPSC lines, and 39 trials

Posted on July 1, 2019 by Statistic Bot ... Continue reading
Total lines2693
hESC lines744
hiPSC lines1949
derivation countries31
projects 136
providers348
... Continue reading
Total lines2662
hESC lines741
hiPSC lines1921
derivation countries31
projects 132
providers337
... Continue reading
Total lines2642
hESC lines741
hiPSC lines1901
derivation countries31
projects 130
providers331
... Continue reading

clinical studies on hPSCreg

Posted on March 28, 2019 by Stefanie Seltmann Due to the great progress in the field of research on pluripotent stem cell lines and their application in the clinical area, hPSCreg now also offers an overview of studies and the associated cell lines. The overview is publicly available here. Registered users also have the option of registering
Total lines2619
hESC lines739
hiPSC lines1880
derivation countries31
projects 127
providers318
... Continue reading

Current status: 739 hESC lines and 1873 hiPSC lines

Posted on March 1, 2019 by Statistic Bot ... Continue reading
Total lines2612
hESC lines739
hiPSC lines1873
derivation countries31
projects 125
providers309
... Continue reading
Total lines2607
hESC lines739
hiPSC lines1868
derivation countries31
projects 123
providers303
... Continue reading
Total lines2604
hESC lines739
hiPSC lines1865
derivation countries31
projects 120
providers293
... Continue reading
Total lines2597
hESC lines738
hiPSC lines1859
derivation countries30
projects 118
providers284
... Continue reading
Total lines2586
hESC lines738
hiPSC lines1848
derivation countries30
projects 118
providers282
... Continue reading
Total lines2570
hESC lines738
hiPSC lines1832
derivation countries30
projects 113
providers272
Total lines2571
hESC lines739
iPSC lines1832
derivation countries30
projects 111
providers256
... Continue reading

Recent Trends in Research with Human Pluripotent Stem Cells

Posted on July 30, 2018 by Stefanie Seltmann We want to highlight a new publication: Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials The human pluripotent stem cell (hPSC) research landscape is rapidly evolving. To assess possible novel trend ... Continue reading

GDPR Policy update

Posted on May 25, 2018 by Stefanie Seltmann We have updated our Terms of Use and Privacy Policy to make it easy for the hPSCreg user to understand what information we have about them, what we do with it, and why. While we believe this updated policy will serve all of our users better, we are making these changes to make sure that we are compl ... Continue reading

New: Provide public comments or feedback for cell lines

Posted on March 6, 2018 by Robert Müller Registered hPSCreg users can now publicly share feedback, experiences or results with the research community for each cell line. When logged in, you can provide comments directly within the cell line details page in the „General“ section. ... Continue reading

Simplification of publishing your lines

Posted on September 19, 2017 by Stefanie Seltmann hPSCreg now provides an automatic, pre-filled word template to publish your cell line in Stem Cell Research - Lab Resources. The template can be downloaded after the cell line has been submitted. For further details click here. ... Continue reading

Current status: 707 hESC lines and 574 iPSC lines

Posted on August 1, 2017 by Statistic Bot ... Continue reading
Total lines1281
hESC lines707
iPSC lines574
derivation countries28
projects 99
providers173
... Continue reading
Total lines1278
hESC lines706
iPSC lines572
derivation countries27
projects 94
providers167
... Continue reading
Total lines1264
hESC lines706
iPSC lines558
derivation countries26
projects 91
providers159
... Continue reading
Total lines1229
hESC lines706
iPSC lines523
derivation countries26
projects 91
providers151
... Continue reading
Total lines1212
hESC lines703
iPSC lines509
derivation countries26
projects 87
providers140
... Continue reading

New API to list hPSCreg names

Posted on February 28, 2017 by Johannes Dewender We have a new public API to list all hPSCreg cell line names and to find the hPSCreg name for a cell line. See the documentation for details.
Total lines1176
hESC lines695
iPSC lines481
derivation countries26
projects 84
providers130
... Continue reading

Current status: 690 hESC lines and 452 iPSC lines

Posted on February 1, 2017 by Statistic Bot ... Continue reading
Total lines1142
hESC lines690
iPSC lines452
derivation countries27
projects 83
providers129
... Continue reading
Total lines1137
hESC lines699
iPSC lines438
derivation countries27
projects 82
providers122
... Continue reading
Total lines1130
hESC lines701
iPSC lines429
derivation countries27
projects 76
providers117
... Continue reading
Total lines1128
hESC lines701
iPSC lines427
derivation countries27
projects 71
providers116
... Continue reading
Total lines1116
hESC lines698
iPSC lines418
derivation countries27
projects 71
providers116
... Continue reading
Total lines1105
hESC lines698
iPSC lines407
derivation countries27
projects 68
providers116
... Continue reading
Total lines1095
hESC lines693
iPSC lines402
derivation countries26
projects 66
providers113
... Continue reading
Total lines1068
hESC lines693
iPSC lines375
derivation countries26
projects 66
providers110
... Continue reading
Total lines1015
hESC lines693
iPSC lines322
derivation countries26
projects 66
providers109
... Continue reading
Total lines1015
hESC lines693
iPSC lines322
derivation countries26
projects 66
providers108
Total lines 848
hESC lines 691
iPSC lines 157
derivation countries 26
projects 64
providers 107
... Continue reading

Partnership with Elsevier’s Journal Stem Cell Research

Posted on August 31, 2015 by Stefanie Seltmann The Human Pluripotent Stem Cell Registry has entered an agreement to publish the description of cell lines registered with hPSCreg under the article type “Lab Resource: Stem Cell Line” in the journal Stem Cell Research. Scientists registering their PSC lines in hPSCreg will have the opportuni ... Continue reading

Press release on BioSpace.com

Posted on June 24, 2015 by Weiping Zhang BioSpace.com features a press release about the Human Pluripotent Stem Cell Registry hPSCreg; "A global registry has been enhanced and expanded to offer more in-depth information and analysis on human pluripotent stem cell lines, including human embryonic (hESC) and adult derived induced pluripot ... Continue reading

World map of ES and iPS cell lines is online

Posted on February 18, 2015 by Fritz Lekschas World map of ES and iPS cell lines is now online. Currently the map shows the (log) number of registered ES and iPS cell lines as well as the legal status for ES cell line research in a heat map fashion. To open the world map click on it or visit hescreg.eu/map. ... Continue reading

The hESCreg portal was publicly relaunched

Posted on November 4, 2014 by Robert Müller The hESCreg portal was publicly relaunched on November 4 at the German Stem Cell Network's (GSCN) annual conference in Heidelberg. The re-launch adds new and expanded functionality to the portal, including an online registration tool for human embryonic and induced pluripotent cell lines and the aut ... Continue reading

Abandoned embryonic stem cell trial to re-start

Posted on June 11, 2014 by Robert Müller The first ever clinical trial using human embryonic stem cell – derived oligodendrocytes has received new funding, after it was abandoned by Geron in 2011 (Nature 479, 459; 2011). The 14.3 million US$ provided by CIRM to Asterias Biotherapeutics of Menlo Park, California will be used to treat and ... Continue reading

Reprogramming by somatic cell nuclear transfer

Posted on June 3, 2014 by Robert Müller Three recent papers have successfully reprogrammed human adult somatic cells by somatic cell nuclear transfer (SCNT) into oocytes (de Souza, 2014). While the first successful human pluripotent NT-line were derived from fetal dermal fibroblasts and dermal fibroblasts from a patient with Leigh syndro ... Continue reading

A New Regulatory System for Stem Cell–Based Therapies in Japan

Posted on June 3, 2014 by Robert Müller The Japanese government has implemented a novel regulatory framework for stem cell based therapies: The Act on the Safety of Regenerative Medicine and the Revised Pharmaceutical Affairs Law. Recognizing that the conventional regulatory framework for pharmaceuticals is unsuitable for cell based regen ... Continue reading

EBiSC – the first European bank for induced pluripotent stem cells

Posted on March 26, 2014 by Hermann Azong A consortium of 26 partners has been formed to establish the “European Bank for induced pluripotent Stem Cells” (EBiSC) with support from the IMI. The EBISC iPS cell bank will act as a central storage and distribution facility for human iPS cells, to be used by researchers across academi ... Continue reading